Ad is loading...
CUTR
Price
$0.32
Change
-$0.01 (-3.03%)
Updated
Nov 15 closing price
93 days until earnings call
NVNO
Price
$3.28
Change
-$0.13 (-3.81%)
Updated
Nov 15 closing price
Earnings call today
Ad is loading...

CUTR vs NVNO

Header iconCUTR vs NVNO Comparison
Open Charts CUTR vs NVNOBanner chart's image
Cutera
Price$0.32
Change-$0.01 (-3.03%)
Volume$279.85K
CapitalizationN/A
enVVeno Medical
Price$3.28
Change-$0.13 (-3.81%)
Volume$67.16K
CapitalizationN/A
CUTR vs NVNO Comparison Chart
Loading...
CUTR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVNO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CUTR vs. NVNO commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CUTR is a Sell and NVNO is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CUTR: $0.32 vs. NVNO: $3.28)
Brand notoriety: CUTR and NVNO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CUTR: 104% vs. NVNO: 43%
Market capitalization -- CUTR: $27.55M vs. NVNO: $72.44M
CUTR [@Medical Specialties] is valued at $27.55M. NVNO’s [@Medical Specialties] market capitalization is $72.44M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CUTR’s FA Score shows that 1 FA rating(s) are green whileNVNO’s FA Score has 0 green FA rating(s).

  • CUTR’s FA Score: 1 green, 4 red.
  • NVNO’s FA Score: 0 green, 5 red.
According to our system of comparison, both CUTR and NVNO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CUTR’s TA Score shows that 3 TA indicator(s) are bullish while NVNO’s TA Score has 5 bullish TA indicator(s).

  • CUTR’s TA Score: 3 bullish, 4 bearish.
  • NVNO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NVNO is a better buy in the short-term than CUTR.

Price Growth

CUTR (@Medical Specialties) experienced а -16.60% price change this week, while NVNO (@Medical Specialties) price change was -6.55% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

CUTR is expected to report earnings on Feb 19, 2025.

NVNO is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVNO($72.4M) has a higher market cap than CUTR($27.5M). NVNO YTD gains are higher at: -36.187 vs. CUTR (-90.809). NVNO has higher annual earnings (EBITDA): -24.69M vs. CUTR (-59.84M). CUTR has more cash in the bank: 223M vs. NVNO (46.4M). NVNO has less debt than CUTR: NVNO (1.4M) vs CUTR (431M). CUTR has higher revenues than NVNO: CUTR (246M) vs NVNO (0).
CUTRNVNOCUTR / NVNO
Capitalization27.5M72.4M38%
EBITDA-59.84M-24.69M242%
Gain YTD-90.809-36.187251%
P/E Ratio434.78N/A-
Revenue246M0-
Total Cash223M46.4M481%
Total Debt431M1.4M30,742%
FUNDAMENTALS RATINGS
CUTR vs NVNO: Fundamental Ratings
CUTR
NVNO
OUTLOOK RATING
1..100
5041
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
9885
P/E GROWTH RATING
1..100
6100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVNO's Valuation (34) in the null industry is somewhat better than the same rating for CUTR (94) in the Medical Specialties industry. This means that NVNO’s stock grew somewhat faster than CUTR’s over the last 12 months.

NVNO's Profit vs Risk Rating (100) in the null industry is in the same range as CUTR (100) in the Medical Specialties industry. This means that NVNO’s stock grew similarly to CUTR’s over the last 12 months.

NVNO's SMR Rating (96) in the null industry is in the same range as CUTR (100) in the Medical Specialties industry. This means that NVNO’s stock grew similarly to CUTR’s over the last 12 months.

NVNO's Price Growth Rating (85) in the null industry is in the same range as CUTR (98) in the Medical Specialties industry. This means that NVNO’s stock grew similarly to CUTR’s over the last 12 months.

CUTR's P/E Growth Rating (6) in the Medical Specialties industry is significantly better than the same rating for NVNO (100) in the null industry. This means that CUTR’s stock grew significantly faster than NVNO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CUTRNVNO
RSI
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Ad is loading...
CUTR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVNO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFS21.400.22
+1.04%
Provident Financial Services
BCE26.82-0.02
-0.07%
BCE
GVA95.61-0.13
-0.14%
Granite Construction
UTMD66.05-0.47
-0.71%
Utah Medical Products
LPCN4.89-0.32
-6.14%
Lipocine

CUTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CUTR has been loosely correlated with MASS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CUTR jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CUTR
1D Price
Change %
CUTR100%
-2.11%
MASS - CUTR
38%
Loosely correlated
+0.42%
QDEL - CUTR
37%
Loosely correlated
-7.14%
STAA - CUTR
37%
Loosely correlated
-2.33%
CERS - CUTR
36%
Loosely correlated
-4.44%
TWST - CUTR
36%
Loosely correlated
-5.31%
More